🇺🇸 FDA
Pipeline program

Tamsulosin Oral Capsule

03-19

Approved small_molecule completed

Quick answer

Tamsulosin Oral Capsule for Ischaemic Heart Disease (IHD) is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Ischaemic Heart Disease (IHD)
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials